Abstract A93: Safety, efficacy and pharmacokinetics of two schedules of navitoclax (ABT-263) in combination with irinotecan: Preliminary results of an open-label phase 1 study von Tolcher, Anthony W., LoRusso, Patricia, Rosen, Lee, de Oliveira, Moacyr Ribeiro, Waring, Jeffrey F., Rudersdorf, Niki, Patel, Raina, Brasher, Carol Ann, Busman, Todd, Cui, Yue, Yang, Jianning, Holen, Kyle

Volltext